Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study

Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study

Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...

Full description

Bibliographic Details
Main Authors: Ashwin R. Moerlie, Renate C. van Uden, Aukje K. Mantel, Patricia van den Bemt, Matthijs L. Becker
Format: Article
Language:English
Published: Centro de Investigaciones y Publicaciones Farmaceuticas 2020-06-01
Series:Pharmacy Practice
Subjects:
platelet aggregation inhibitors
fibrinolytic agents
guideline adherence
medication errors
hemorrhage
risk factors
pharmacists
clinical audit
netherlands
Online Access:https://pharmacypractice.org/journal/index.php/pp/article/view/1803

Internet

https://pharmacypractice.org/journal/index.php/pp/article/view/1803

Similar Items